Ads
related to: revlimid approved indications for diabetes treatment guidelines- Patient Support
Get A Free 30 Minute Consultation
With A Certified Diabetes Educator
- Savings Card
Are You Eligible For Savings?
See If You Qualify Here.
- Cardiovascular Risk
Learn About The Connection Between
Type 2 Diabetes & CV Risk
- Dosing Information
Find Dosing Info & Guidance
For Getting Started.
- Patient Support
explorefrog.com has been visited by 10K+ users in the past month
trustedhippo.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]
Exenatide (also Exendin-4, marketed as Byetta) is the first GLP-1 agonist approved for the treatment of type 2 diabetes. Exenatide is not an analogue of GLP but rather a GLP agonist. [32] [33] Exenatide has only 53% homology with GLP, which increases its resistance to degradation by DPP-4 and extends its half-life. [34]
The thalidomide molecule is a synthetic derivative of glutamic acid and consists of a glutarimide ring and a phthaloyl ring (Figure 5). [15] [16] Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione and it has one chiral center [15] After thalidomide's selective inhibition of TNF-α had been reported, a renewed effort was put in thalidomide's clinical development.
Celgene (CELG) receives positive CHMP opinion for label expansions of IMiD medications - Revlimid and Imnovid.
The Food and Drug Administration has granted approval to Invokana, a Type 2 diabetes drug manufactured by a unit of Johnson & Johnson . The drug is part of a new class of treatments known as SGLT2 ...
Teplizumab, sold under the brand name Tzield, is a humanized anti-CD3 monoclonal antibody that is the first approved treatment indicated to delay the onset of stage 3 type 1 diabetes in people with stage 2 type 1 diabetes. [3] [4] [5] The Fc region of this antibody has been engineered to have Fc receptor non-binding (FNB) properties. [6]
Ads
related to: revlimid approved indications for diabetes treatment guidelinesexplorefrog.com has been visited by 10K+ users in the past month
trustedhippo.com has been visited by 100K+ users in the past month